What’s Going On With Intel Shares Today?
Intel Corporation (NASDAQ: INTC) shares are trading marginally lower by 0.92% to $39.81 during Thursday's trading session in anticipation of the company's second-quarter earnings report.
Trading Ford’s Q2 Earnings Move On ‘PreMarket Prep’
When an issue makes a large move in the after-hours or premarket session off an earnings report, it can be difficult to determine whether the move will continue in that direction.
What’s Going On With Roku Stock Today?
Roku Inc (NASDAQ: ROKU) shares are trading lower by 1.6% to $85.55 during Thursday's trading session in anticipation of the company's second-quarter earnings report.
Cognizant Gets mixed Reviews From Analysts On Q2Performance, But All Trim Price Targets
Analysts reserved mixed opinions on Cognizant Technology Solutions Corp (NASDAQ: CTSH)
Visteon Shares Gain On Better-Than-Expected Q2 Earnings
Visteon Corp (NASDAQ:VC) reported second-quarter FY22 sales growth of 42% year-on-year, to $848 million, beating the consensus of $719.49 million. The…
Why Bitcoin And Ethereum Are Surging Today
The crypto market is soaring Thursday, led by Bitcoin (CRYPTO: BTC) and Ethereuem (CRYPTO: ETH), after the Federal Reserve
Cryptocurrency Stellar Up More Than 10% In 24 hours
Stellar's (CRYPTO: XLM) price has increased 10.05% over the past 24 hours to $0.12. Over the past week, XLM has experienced an uptick of over 4.0%, moving from $0.11 to its current price. As it stands right now, the coin's all-time high is $0.88.
Cryptocurrency VeChain Up More Than 12% In 24 hours
Over the past 24 hours, VeChain's (CRYPTO: VET) price has risen 12.5% to $0.03. This continues its positive trend over the past week where it has experienced a 4.0% gain, moving from $0.03 to its current price. As it stands right now, the coin's all-time high is $0.28.
Why Bausch Health’s Market Cap Was Chopped In Half Thursday: ‘A Near Worst-Case Scenario’
Shares of global health company Bausch Health Companies Inc (NYSE: BHC) are plunging Thursday after a Delaware federal judge issued an oral order on patents related to the company's Xifaxan drug.
Pitney Bowes Shares Drop As Q2 Earnings Falls Short
Pitney Bowes Inc (NYSE:PBI) reported a second-quarter FY22 sales decline of 3.1% year-on-year to $871.5 million, missing the analyst consensus of…